This department is offering grants to support small business concerns in the United States to develop biomedical technologies with commercial potential. The funding encourages R&D projects that have already completed the prototype stage, similar to Phase-I SBIR projects. The Direct-to-Phase II grant aims to accelerate technology development and commercialization, providing opportunities for small businesses to expand their research. The closing date for applications is January 7, 2017.
Opportunity ID: 250913
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-088 |
Funding Opportunity Title: | Direct Phase II SBIR Grants to Support Biomedical Technology Development |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Feb 05, 2014 |
Last Updated Date: | Feb 19, 2014 |
Original Closing Date for Applications: | Jan 07, 2017 |
Current Closing Date for Applications: | Jan 07, 2017 |
Archive Date: | Feb 07, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism. Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance the pace of technology development and commercialization. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Added CFDA number 93.273, per NIAAA’s participation. | Feb 19, 2014 | |
Added CFDA’s per NINDS participation. | Feb 19, 2014 | |
Feb 05, 2014 |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-088 |
Funding Opportunity Title: | Direct Phase II SBIR Grants to Support Biomedical Technology Development |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Feb 05, 2014 |
Last Updated Date: | Feb 19, 2014 |
Original Closing Date for Applications: | Jan 07, 2017 |
Current Closing Date for Applications: | Jan 07, 2017 |
Archive Date: | Feb 07, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism. Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance the pace of technology development and commercialization. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-088 |
Funding Opportunity Title: | Direct Phase II SBIR Grants to Support Biomedical Technology Development |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Feb 19, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jan 07, 2017 |
Archive Date: | Feb 07, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism. Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance the pace of technology development and commercialization. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-088 |
Funding Opportunity Title: | Direct Phase II SBIR Grants to Support Biomedical Technology Development |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Feb 05, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jan 07, 2017 |
Archive Date: | Feb 07, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism. Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance the pace of technology development and commercialization. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00192550 | Mar 05, 2014 | Sep 07, 2014 | View | |
FORMS-C | Use for due dates on or after August 5, 2014 | PKG00197063 | Mar 05, 2014 | Jun 08, 2016 | View | |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00224110 | Aug 05, 2016 | Jan 07, 2017 | View |
Package 1
Mandatory forms
250913 RR_SF424_1_2-1.2.pdf
250913 PerformanceSite_1_4-1.4.pdf
250913 RR_OtherProjectInfo_1_3-1.3.pdf
250913 RR_KeyPersonExpanded_1_2-1.2.pdf
250913 RR_Budget-1.1.pdf
250913 PHS398_CoverPageSupplement_1_4-1.4.pdf
250913 PHS398_ResearchPlan_1_3-1.3.pdf
250913 PHS398_Checklist_1_3-1.3.pdf
250913 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
250913 RR_SubawardBudget30-1.2.pdf
250913 PHS_CoverLetter_1_2-1.2.pdf
Package 2
Mandatory forms
250913 RR_SF424_2_0-2.0.pdf
250913 PHS398_ResearchPlan_2_0-2.0.pdf
250913 SBIR_STTR_Information_1_1-1.1.pdf
250913 RR_KeyPersonExpanded_2_0-2.0.pdf
250913 RR_OtherProjectInfo_1_3-1.3.pdf
250913 RR_Budget_1_3-1.3.pdf
250913 PerformanceSite_2_0-2.0.pdf
250913 PHS398_CoverPageSupplement_2_0-2.0.pdf
Optional forms
250913 RR_SubawardBudget30_1_3-1.3.pdf
250913 PlannedReport-1.0.pdf
250913 PHS398_CumulativeInclusionReport-1.0.pdf
Package 3
Mandatory forms
250913 RR_SF424_2_0-2.0.pdf
250913 PHS398_CoverPageSupplement_3_0-3.0.pdf
250913 RR_OtherProjectInfo_1_3-1.3.pdf
250913 PerformanceSite_2_0-2.0.pdf
250913 RR_KeyPersonExpanded_2_0-2.0.pdf
250913 RR_Budget_1_3-1.3.pdf
250913 PHS398_ResearchPlan_3_0-3.0.pdf
250913 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
250913 RR_SubawardBudget30_1_3-1.3.pdf
250913 PHS_Inclusion_Enrollment_Report-1.0.pdf
250913 PHS_AssignmentRequestForm-1.0.pdf